INOVIO Receives New $5 Million Grant to Accelerate Scale Up of Smart Delivery Device for Its COVID-19 Vaccine

Disease prevention

Home » Health and medicine » Disease prevention

Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus

PLYMOUTH MEETING, Pa., Jan. 23, 2020 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to $9...

Meissa Vaccines Receives U.S. FDA Fast Track Designation for Respiratory Syncytial Virus Vaccine, MV-012-968

The End Of The Flu: Can We Immunize The World Against A Seasonal Killer?

Christmas season just ended, and there’s a good chance you heard John Lennon’s “Xmas Time” on the radio. Lennon wrote the song with Yoko Ono as a Vietnam War protest as well, singing near the end, “The war is over, if...

Codagenix Raises $20 Million in Series B Funding for Continued Development of RSV, Influenza and Oncolytic Virus Products

Prokarium Announces MHRA Acceptance to Run Phase I Trial of Lead Vaccine Against Enteric Fever

Health care

British Biotech Company Sees Hope In Reducing Mosquito-Borne Diseases And Deaths With GMOs

Oxitec Successfully Completes First Field Deployment of 2nd Generation Friendly™ Aedes aegypti Technology

Codagenix Inc. Announces Award of $1M US Army Contract for Continued Development of Contemporary, Balanced Dengue Vaccine

Meissa Vaccines Closes $3.4 Million Financing to Advance RSV Vaccine to Clinic

Amyris Is Selected by NIH Grant Recipient, IDRI, to Engineer Molecules for Vaccine Adjuvant Applications

Oxitec Transitioning Friendly™ Self-limiting Mosquitoes to 2nd Generation Technology Platform, Paving Way to New Scalability, Performance and Cost Breakthroughs

Oxitec

Oxitec to Develop 2nd Friendly™ Mosquito Strain Designed to Combat Malaria-Spreading Mosquitoes

Inovio

Inovio’s Ebola Vaccine Provides 100% Protection And Elicits Long-Lasting Immune Responses in Preclinical Studies

Inovio Develops Novel H3N2 Influenza DNA Vaccine That Generates Cross-Reactive Responses and Provides Complete Protection Against Lethal Preclinical Challenges

Genetically modified mosquitoes may be best weapon for curbing disease transmission